Pakistan Study of Premature Coronary Atherosclerosis in Young Adults
Recruiting
Observational Study
Atherosclerotic PlaqueDiabetes Mellitus, Type 2HypertensionStroke
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
35 – 65
Sex
Any
Study type
Observational
Participants needed
2,000 (estimated)
Sponsor
Tabba Heart Institute · Other
Who this trial is looking for
This trial is looking for healthy Pakistani men and women aged 35 to 65. Participants will undergo exams and tests to assess heart health over 5 years.
Are You a Good Fit for This Trial?
You may be able to join if
I am a native Pakistani
I am a man aged 35 to 60 years or a woman aged 35 to 65 years
I am willing to participate in the study
You may not be able to join if
I have an eGFR below 60 ml/min/1.73m2
I am pregnant
I have had a stroke or heart attack in the past
I have a history of peripheral artery disease
I weigh more than 102 kg
I have any active cancer
I have a contraindication to the contrast used in tests
I expect to move from my home area in the next 5 years
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Coronary heart disease (CHD) is a major cause of morbidity, disability, mortality, and health expenditures worldwide. A wealth of studies has demonstrated that people of South Asian ancestry have a higher risk of CHD and particularly premature CHD than most other racial/ethnic groups, and recent research suggests that this risk is higher in Pakistanis than in Indians-the two largest SA groups. Pak…
Coronary heart disease (CHD) is a major cause of morbidity, disability, mortality, and health expenditures worldwide. A wealth of studies has demonstrated that people of South Asian ancestry have a higher risk of CHD and particularly premature CHD than most other racial/ethnic groups, and recent research suggests that this risk is higher in Pakistanis than in Indians-the two largest SA groups. Pakistan is the 5th most populous country in the world, and despite these concerning trends, so far there has been a scarcity of large studies evaluating the prevalence of cardiovascular risk factors and subclinical coronary atherosclerosis in young-to-middle-aged Pakistanis. Also, there is currently no cardiovascular risk score specifically tailored to younger Pakistani men and women. The PAKistan Study of prEmature coronary atHerosclerosis in young AdulTs (PAK-SEHAT) aims at addressing these important gaps. PAK-SEHAT is an ongoing prospective cohort study that will enroll 2,000 asymptomatic Pakistani men aged 35 to 60 years and women aged 35 to 65 years from the general population, free of clinically overt cardiovascular disease. Participants will undergo a comprehensive baseline exam including coronary computed tomography angiography, and will be followed for incident events and repeat testing for 5 years. PAK-SEHAT will allow determining the prevalence, severity, determinants, and prognostic significance of early atherosclerosis in apparently healthy young-to-middle-aged Pakistanis. This knowledge can help inform primordial and primary prevention strategies, enhanced cardiovascular risk stratification, and potential plaque-screening approaches in Pakistan, all of which can ultimately help reduce the burden of CHD in the country. In this report investigators describe the rationale, objectives, methods, and discuss the potential implications of the PAK-SEHAT study.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* Native Pakistani
* Men aged 35-60 years \& women aged 35-65 years
* Willing to consent to participation
Exclusion Criteria:
eGFR \< 60 ml/min/1.73m2
Pregnant women
History of stroke or MI (CABG or PCI)
History of Peripheral arterial disease
Weight more than 102 Kg
Any a…
Inclusion Criteria:
* Native Pakistani
* Men aged 35-60 years \& women aged 35-65 years
* Willing to consent to participation
Exclusion Criteria:
eGFR \< 60 ml/min/1.73m2
Pregnant women
History of stroke or MI (CABG or PCI)
History of Peripheral arterial disease
Weight more than 102 Kg
Any active malignancy
Known contraindication from contrast used in cardiac CTA
Expected migration from residential area within 5 years
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.